All Stories

  1. Development of a prelabeling approach for a targeted nanochelator
  2. Influence of Charge on Cell Permeability and Tumor Imaging of GPR30-Targeted 111 In-Labeled Nonsteroidal Imaging Agents
  3. Managing the unmanageable
  4. Enhancement of somatostatin-receptor-targeted 177Lu-[DOTA0-Tyr3]-octreotide therapy by gemcitabine pretreatment-mediated receptor uptake, up-regulation and cell cycle modulation
  5. Somatostatin-receptor-targeted α-emitting 213Bi is therapeutically more effective than β−-emitting 177Lu in human pancreatic adenocarcinoma cells
  6. Synthesis and evaluation of a water-soluble polymer to reduce Ac-225 daughter migration
  7. Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator
  8. A Comparison of High- Versus Low-Linear Energy Transfer Somatostatin Receptor Targeted Radionuclide Therapy In Vitro
  9. Comparison of Sensitivities of Cells to X-Ray Therapy, Chemotherapy, and Isotope Therapy Using a Tumor Spheroid Model
  10. An improved and facile method for the synthesis of 1,1-bis(4-hydroxyphenyl)-2-phenylethylene and its derivatives
  11. High and low let particle-emitting isotopes for therapy: A comparison of cytotoxicity and dose-rate effects
  12. Characterization and utilization of a monoclonal antibody against pancreatic carcinoma
  13. Morphological, Biochemical, and Molecular Changes in Endothelial Cells after Alpha-Particle Irradiation
  14. Preparation and evaluation of para-[211At]astatobenzoyl labeled anti-renal cell carcinoma antibody A6H F(ab′)2. In vivo distribution comparison with para-[125I]iodobenzoyl labeled A6H F(ab′)2
  15. G2M arrest and apoptosis in murine T lymphoma cells following exposure to 212Bi alpha particle irradiation
  16. Localization of Sarcoma Xenografts in Nude Mice with Indium-111-Labeled Monoclonal Antibodies
  17. A revised method for the synthesis of 1,1-Bis(4-hydroxyphenyl)-2-phenylethylene (BHPE) and its derivatives
  18. MURINE HEMATOPOIETIC ABLATION BY ALPHA-PARTICLE-EMITTING RADIOPHARMACEUTICALS - A POTENTIAL PREPARATIVE REGIMEN FOR BONE-MARROW TRANSPLANTATION
  19. Induction of Mutations by Bismuth-212 α Particles at Two Genetic Loci in Human B-Lymphoblasts
  20. Accumulation of indium-111-labeled human low density lipoprotein in the rabbit aorta: Implications for nuclear imaging of vascular lesions
  21. Cellular Kinetics, Dosimetry, and Radiobiology of α-Particle Radioimmunotherapy: Induction of Apoptosis
  22. Interlaboratory Comparison of Different Alpha-particle and Radon Sources
  23. Intraperitoneal (ip) administration of the high-linear energy transfer α-emitting radionuclide lead-212
  24. Analysis of ascites from patients with ovarian carcinoma by cell flow cytometry
  25. Radiobiologic basis of lymphoma radio-immunotherapy
  26. In Vitro Exposure of Mammalian Cells to Radon: Dosimetric Considerations
  27. Astatine-211 labeling of an antimelanoma antibody and its Fab fragment using N-succinimidyl p-[211At]astatobenzoate: comparisons in vivo with the p-[125I]iodobenzoyl conjugate
  28. The effects of radon daughter α-particle irradiation in K1 and xrs-5 CHO cell lines
  29. A National Biomedical Tracer Facility (NBTF)
  30. Increased Nuclear Damage by High Linear Energy Transfer Radioisotopes Applicable for Radiodirected Therapy against Radiologic Malignancies
  31. Differential locus sensitivity to mutation induction by ionizing radiations of different LETs in Chinese hamster ovary K1 cells
  32. ALPHA RADIATION-INDUCED G2M ARREST IN MURINE LYMPHOMA CELLS
  33. Controlled release biodegradable polymers for biologically targeted alpha-particle-emitting radiopharmacelitical therapy
  34. DNA DAMAGE AND SURVIVAL OF V79 CELLS IN CULTURE FOLLOWING THE EXTRACELLULAR DECAY OF BISMUTH-212
  35. Modeling of dose to tumor and normal tissue from intraperitoneal radioimmunotherapy with alpha and beta emitters
  36. Comparison of short-lived high-LET α-emitting radionuclides lead-212 and bismuth-212 to low-LET X-rays on ovarian carcinoma
  37. Comparison of short-lived high-LET α-emitting radionuclides lead-212 and bismuth-212 to low-LET X-rays on ovarian carcinoma
  38. Radiometal labeling of immunoproteins: covalent linkage of 2-(4-isothiocyanatobenzyl)diethylenetriaminepentaacetic acid ligands to immunoglobulin
  39. Optimization of parameters in radioimmunotherapy
  40. Comparison of radon-daughter-induced effects in repair-proficient and repair-deficient cho cell lines
  41. The inherent cellular radiosensitivity of epithelial ovarian carcinoma
  42. Comparison of short-lived high-LET α-emitting radionuclides lead-212 and bismuth-212 to low-LET X-rays on ovarian carcinoma
  43. Resident's essay award: Alpha particle radio-immunotherapy: Animal models and clinical prospects
  44. The development of α-emitting radionuclide lead 212 for the potential treatment of ovarian carcinoma
  45. Halogenated Pyrimidines as Radiosensitizers for High-LET Radiation
  46. The effect of the α-emitting radionuclide lead-212 on human ovarian carcinoma: A potential new form of therapy
  47. A radionuclide generator for the production of211Pb and its daughters
  48. Three dimensional dose modelling of alpha and beta particle emitters for intraperitoneal radioimmunotherapy
  49. Analysis of ascites from patients with ovarian carcinoma by cell flow cytometry
  50. A 212Pb radiocolloid for intracavitary therapy
  51. Radioimmunotherapy with alpha-particle-emitting immunoconjugates
  52. 212Bismuth Linked to an Antipancreatic Carcinoma Antibody: Model for Alpha-Particle-Emitter Radioimmunotherapy
  53. An improved generator for the production of 212Pb and 212Bi from 224Ra
  54. Radioimmunotherapy with alpha particle emitting monoclonal antibodies
  55. A remote system for the separation of228Th and224Ra
  56. Radionuclide-conjugated monoclonal antibodies: a synthesis of immunology, inorganic chemistry and nuclear science
  57. Synthesis of 1-(p-isothiocyanatobenzyl) derivatives of DTPA and EDTA. Antibody labeling and tumor-imaging studies
  58. Treatment of rheumatoid synovitis of the knee with intraarticular injection of dysprosium 165-ferric hydroxide macroaggregates
  59. Bismuth-212-labeled anti-Tac monoclonal antibody: alpha-particle-emitting radionuclides as modalities for radioimmunotherapy.
  60. 211At radiocolloid therapy: Further observations and comparison with radiocolloids of 32P, 165Dy, and 90Y
  61. Generator-Produced Bi-212
  62. Intra-articular Radiation Synovectomy
  63. Production of 52Fe for use in a radionuclide generator system
  64. Retention of Plutonium and Americium by Rock
  65. Annual report for FY 1976 on project AN0115A: the migration of plutonium and americium in the lithosphere
  66. The Migration of Plutonium and Americium in the Lithosphere
  67. Comparison of neutron resonance spacings with microscopic theory for spherical nuclei
  68. Comparison of neutron resonance spacings with microscopic theory for nuclei with static deformation